Success Stories: NIW Approval for Researcher Creating Novel Molecules to Fight Cancer and Infections with NAILG’s Support

Posted by wegreened on January 30, 2026 in Biotechnology, NIW

Client’s Testimonial:

“Excellent work! The team at Chen Immigration Attorneys demonstrated exceptional attention to detail, thoroughly addressing all my questions and concerns. They meticulously checked every aspect of my case, providing clear and thorough explanations. I truly appreciate their professionalism and dedication. Highly recommend!”

On February 26^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Senior Associate, Research Scientist

Country of Origin: Nepal

Country of Residence at the Time of Filing: Canada

Approval Notice Date: February 26^th, 2025

Processing Time: 1 month, 27 days (Premium Processing Requested)

Case Summary:

Drug resistance, cancer, and bacterial infections remain some of the greatest health threats facing the United States today. To confront these challenges, a biotechnology researcher has dedicated his career to developing therapeutic molecules through structure-based enzyme engineering, an approach that promises safer, more effective treatments.

His work has already demonstrated the ability to generate molecules with anticancer properties while also opening new avenues for treating antibiotic-resistant infections. These contributions directly align with urgent national needs, where innovation in therapeutic design can save lives, reduce healthcare costs, and strengthen the country’s preparedness against emerging health crises.

The significance of his research is reflected in both his record and the recognition he has received:

5 peer-reviewed journal articles, including 1 first-authored.
38 citations of his publications.
Research supported by Taiwan’s Ministry of Science and Technology.

Peers in the scientific community have underscored the critical importance of his work:
“His work provides essential tools that aid in developing safer, more targeted therapies, keeping the United States at the forefront of medical innovation and enhancing its capacity to respond to emerging health threats effectively.”

Recognizing the national value of this research, North America Immigration Law Group (NAILG) structured a petition that emphasized both the scientific merit and the far-reaching impact of his proposed endeavor. USCIS approved his NIW petition, validating the strength of his record and the potential of his contributions to strengthen the U.S. biomedical landscape.

This approval ensures that his expertise in enzyme engineering will continue to advance innovation in life-saving therapies, positioning him to play a vital role in addressing today’s most pressing medical challenges.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%